Abstract
The development of tissue micro-array (TMA) technologies provides insights into high-throughput analysis of proteomics patterns from a large number of archived tumour samples. In the work reported here, matrix-assisted laser desorption/ionisation–ion mobility separation–mass spectrometry (MALDI–IMS–MS) profiling and imaging methodology has been used to visualise the distribution of several peptides and identify them directly from TMA sections after on-tissue tryptic digestion. A novel approach that combines MALDI–IMS–MSI and principal component analysis–discriminant analysis (PCA–DA) is described, which has the aim of generating tumour classification models based on protein profile patterns. The molecular classification models obtained by PCA–DA have been validated by applying the same statistical analysis to other tissue cores and patient samples. The ability to correlate proteomic information obtained from samples with known and/or unknown clinical outcome by statistical analysis is of great importance, since it may lead to a better understanding of tumour progression and aggressiveness and hence improve diagnosis, prognosis as well as therapeutic treatments. The selectivity, robustness and current limitations of the methodology are discussed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Wang J, Bø TH, Jonassen I et al (2003) Tumor classification and marker gene prediction by feature selection and fuzzy c-means clustering using microarray data. BMC Bioinformatics 4:60
Demichelis F, Magni P, Piergiorgi P et al (2006) A hierarchical naïve Bayes model for handling sample heterogeneity in classification problems: an application to tissue microarrays. BMC Bioinformatics 7:514
Abd El-Rehim DM, Ball G, Pinder SE et al (2005) High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses. Int J Cancer 116:340–350
Battifora H, Mehta P (1990) The checkerboard tissue block. An improved multitissue control block. Lab Invest 63:722–724
Kononen J, Bubendorf L, Kallioniemi A et al (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4:844–847
Rosen DG, Huang X, Deavers MT et al (2004) Validation of tissue microarray technology in ovarian carcinoma. Mod Pathol 17:790–797
Kleiner HE, Krishnan P, Tubbs J et al (2009) Tissue microarray analysis of eIF4E and its downstream effector proteins in human breast cancer. J Exp Clin Cancer Res 28:5
Caprioli RM, Farmer TB, Gile J (1997) Molecular imaging of biological samples: localization of peptides and proteins using MALDI-TOF MS. Anal Chem 69:4751–4760
Chaurand P, Schwartz SA, Caprioli RM (2004) Assessing protein patterns in disease using imaging mass spectrometry. J Proteome Res 3:245–252
Stoeckli M, Staab D, Schweitzer A et al (2007) Imaging of a beta-peptide distribution in whole-body mice sections by MALDI mass spectrometry. J Am Soc Mass Spectrom 18:1921–1924
Chaurand P, Sanders ME, Jensen RA, Caprioli RM (2004) Proteomics in diagnostic pathology: profiling and imaging proteins directly in tissue sections. Am J Pathol 165:1057–1068
Reyzer ML, Caldwell RL, Dugger TC et al (2004) Early changes in protein expression detected by mass spectrometry predict tumor response to molecular therapeutics. Cancer Res 64:9093–9100
Groseclose MR, Massion PP, Chaurand P, Caprioli RM (2008) High-throughput proteomic analysis of formalin-fixed paraffin-embedded tissue microarrays using MALDI imaging mass spectrometry. Proteomics 8:3715–3724
Djidja M, Carolan V, Loadman PM, Clench MR (2008) Method development for protein profiling in biological tissues by matrix-assisted laser desorption/ionisation mass spectrometry imaging. Rapid Commun Mass Spectrom 22:1615–1618
Trim PJ, Atkinson SJ, Princivalle AP et al (2008) Matrix-assisted laser desorption/ionisation mass spectrometry imaging of lipids in rat brain tissue with integrated unsupervised and supervised multivariant statistical analysis. Rapid Commun Mass Spectrom 22:1503–1509
Deininger SO, Ebert MP, Fütterer A et al (2008) MALDI imaging combined with hierarchical clustering as a new tool for the interpretation of complex human cancers. J Proteome Res 7:5230–5236
Lemaire R, Desmons A, Tabet JC et al (2007) Direct analysis and MALDI imaging of formalin-fixed, paraffin-embedded tissue sections. J Proteome Res 6:1295–1305
Djidja MC, Francese S, Loadman PM et al (2009) Detergent addition to tryptic digests and ion mobility separation prior to MS/MS improves peptide yield and protein identification for in situ proteomic investigation of frozen and formalin-fixed paraffin-embedded adenocarcinoma tissue sections. Proteomics 9:2750–2763
Armstrong DW, Zhang LK, He L, Gross ML (2001) Ionic liquids as matrixes for matrix-assisted laser desorption/ionization mass spectrometry. Anal Chem 73:3679–3686
Lemaire R, Tabet JC, Ducoroy P et al (2006) Solid ionic matrixes for direct tissue analysis and MALDI imaging. Anal Chem 78:809–819
Pringle SD, Giles K, Wildgoose JL et al (2007) An investigation of the mobility separation of some peptide and protein ions using a new hybrid quadrupole/travelling wave IMS/oa-ToF instrument. Int J Mass Spectrom 261:1–12
Riba-Garcia I, Giles K, Bateman RH, Gaskell SJ (2008) Evidence for structural variants of a- and b-type peptide fragment ions using combined ion mobility/mass spectrometry. J Am Soc Mass Spectrom 19:609–613
Xia Q, Wang HX, Wang J et al (2004) Nano-ESI–MS/MS identification on differentiation-associated proteins in M1 mouse myeloid leukemia cells induced by IL-6. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 26:483–487
Hoogerbrugge R, Willig SJ, Kistemaker PG (1983) Discriminant analysis by double stage principal component analysis. Anal Chem 55:1710–1712
Defernez M, Kemsley EK (1997) The use and misuse of chemometrics for treating classification problems. TrAC Trends Anal Chem 16:216–221
Neoptolemos JP, Dunn JA, Stocken DD et al (2001) Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet 358:1576–1585
Armstrong T, Packham G, Murphy LB et al (2004) Type I collagen promotes the malignant phenotype of pancreatic ductal adenocarcinoma. Clin Cancer Res 10:7427–7437
Ariapart P, Bergstedt-Lindqvist S, van Harmelen V et al (2002) Resection of pancreatic cancer normalizes the preoperative increase of tumor necrosis factor alpha gene expression. Pancreatology 2:491–494
Acknowledgment
This work was supported by funding from the Sheffield Hallam University Clinical Research Fellow scheme.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary materials
Below is the link to the electronic supplementary material.
ESM 1
(PDF 640 kb)
Rights and permissions
About this article
Cite this article
Djidja, MC., Claude, E., Snel, M.F. et al. Novel molecular tumour classification using MALDI–mass spectrometry imaging of tissue micro-array. Anal Bioanal Chem 397, 587–601 (2010). https://doi.org/10.1007/s00216-010-3554-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-010-3554-6